Enquiry/Quote

How to Source Mirtazapine 30 mg Tablets for Pharmaceutical Formulation

Mirtazapine 30 mg Tablets (Tablets/ODT, 15 mg, 30 mg, 45 mg) is classified under Antipsychotropic Drugs. It is therapeutically aligned with reference brands such as US: Remeron®, Remeron SolTab®; EU: Zispin®, Mirtazapine Teva®, Mirtazon®, Espran®. This guide highlights key sourcing factors buyers should consider when procuring high-quality Mirtazapine 30 mg Tablets for formulation, R&D, or bulk manufacturing.

Product Overview: Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA) that enhances norepinephrine and serotonin neurotransmission by blocking central presynaptic α2-adrenergic receptors. It is used to treat major depressive disorder (MDD), offering fast onset of action, improved sleep, and appetite stimulation. ODT formulation improves compliance in patients with swallowing difficulties. Mirtazapine Tablets and Orally Disintegrating Tablets (ODT) are FDA-approved in the USA for the trea...

Mirtazapine 30 mg Tablets API in Tablets/ODT form, 15 mg, 30 mg, 45 mg specification
Mirtazapine 30 mg Tablets API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.

1. Regulatory Compliance & Documentation

Ensure suppliers provide:

2. Purity, Grade & Specification Matching

Mirtazapine 30 mg Tablets must meet exact grade and purity for your dosage form:

3. Supplier Reliability & Audit History

4. Commercial Terms: Pricing, MOQ & Flexibility

5. Lead Time, Inventory & Logistics

Typical lead time for Mirtazapine 30 mg Tablets is 4–6 weeks.

6. Formulation Support

Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.

Conclusion

Sourcing Mirtazapine 30 mg Tablets is more than procurement—it’s a strategic partnership. With its tablets/odt form and 15 mg, 30 mg, 45 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.

Next Step: Get expert assistance in sourcing Mirtazapine 30 mg Tablets.

Request a Quote

Frequently Asked Questions For Sourcing of Mirtazapine 30 mg Tablets

What is the typical lead time for Mirtazapine 30 mg Tablets?

Lead times range from 4–6 weeks depending on supplier and region.

Is Mirtazapine 30 mg Tablets available in multiple grades?

Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.

Does Mirtazapine 30 mg Tablets require special storage?

It should be stored in a cool, dry place away from direct sunlight.

Is a Drug Master File (DMF) available for Mirtazapine 30 mg Tablets?

Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.

Can I request samples or a pilot batch of Mirtazapine 30 mg Tablets?

Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.

What compliance certificates are available for Mirtazapine 30 mg Tablets?

Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.

Is Mirtazapine 30 mg Tablets suitable for regulated markets like US/EU?

Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.

Can Mirtazapine 30 mg Tablets be used in fixed-dose combinations?

Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.